Intellectual Property vs. Public Health in Vaccine Distribution

This chapter critiques the approach taken by a prominent foundation and its reliance on intellectual property rights during the COVID-19 pandemic, emphasizing the inequities in vaccine access. It contrasts profit-driven models against the necessity for open-source vaccine production, highlighting the moral obligation to support equitable healthcare. The discussion reflects on the influence of wealthy individuals in shaping public health policy, questioning the implications of prioritizing corporate interests over humanitarian needs.